Antengene to Host 2023 R&D Day and Discuss Key Data with KOLs
/PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading commercial-stage innovative, global biopharmaceutical company dedicated to...
Source: prnewswire.com
Bing Hou News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Bing Hou. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Bing Hou Today - Breaking & Trending Today
Antengene Announces Clearance of U.S. IND for the Phase I Trial of First-in-Class Anti-CD24 Monoclonal Antibody ATG-031
/PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to...
Source: prnewswire.com
Antengene Announces Upcoming Presentations at the 2022 Society for Immunotherapy of Cancer Annual Meeting
/PRNewswire/ -- At the 37th Society for Immunotherapy of Cancer Annual Meeting (SITC 2022), set to take place on November 8-12, 2022, in Boston, Massachusetts...
Source: prnewswire.com
Antengene to Present Data of Its PD-L1/4-1BB Bispecific Antibody ATG-101 and ERK1/2 Inhibitor ATG-017 at SITC 2021
/PRNewswire/ -- The 36th Annual Meeting of the Society for Immunotherapy for Cancer (SITC 2021) will take place in Washington, D.C., United States, on November...
Source: prnewswire.com